Cited by 1,345BRCA gene mutations in cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Germline Mutations in Predisposition Genes in Pediatric Cancer

Open access

Zhang, Jinghui, Walsh, Michael F., Wu, Gang, Edmonson, Michael N., Gruber, Tanja A., Easton, John, Hedges, Dale, Ma, Xiaotu, Zhou, Xin, Yergeau, Donald A., Wilkinson, Mark R., Vadodaria, Bhavin, Chen, Xiang, McGee, Rose B., Hines-Dowell, Stacy, Nuccio, Regina, Quinn, Emily, Shurtleff, Sheila A., Rusch, Michael, Patel, Aman, Becksfort, Jared B., Wang, Shuoguo, Weaver, Meaghann S., Ding, Li, Mardis, Elaine R., Wilson, Richard K., Gajjar, Amar, Ellison, David W., Pappo, Alberto S., Pui, Ching-Hon, Nichols, Kim E., Downing, James R.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1508054PMC PMC4734119

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508054

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation

Show all 56 references

Research works printed but not linked: 3

Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
Meldrum C, 2011, Clin Biochem Rev, 32, 177
Armes JE, 1999, Cancer Res, 59, 2011

Sorted by citations

Items 701–800 of 1,000

Creating a cancer genomics curriculum for pediatric hematology‐oncology fellows: A national needs assessment
Murray, A., McGee, R. B., Mostafavi, R. M., Wang, X., Lu, Z., Valdez, J. M., Terao, M. A., & Nichols, K. E. (2021) · Cancer Medicine · doi:10.1002/cam4.3787 · Cited by 6
Self-citation
Mesenchymal Tumors of the Mediastinum: An Update on Diagnostic Approach
Choi, J. H., & Ro, J. Y. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000306 · Cited by 6
Molecular Genetics of Pediatric Acute Myeloid Leukemia
Krock, B. L., & Oberley, M. J. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.03.014 · Cited by 6
Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit
Escudero, A., Ferreras, C., Rodrı́guez-Salas, N., Corral, D., Rodríguez, L., & Pérez‐Martínez, A. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02133-9 · Cited by 6
Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
Poyer, F., Dieckmann, K. U., Dworzak, M. N., Tamesberger, M., Haas, O. A., Jones, N., Nebral, K., Köhrer, S., Moser, R., Kropshofer, G., et al. (2022) · eJHaem · doi:10.1002/jha2.488 · Cited by 6
Cancer carrier screening in the general population using whole‐genome sequencing
Chang, Y., Chao, D., Chung, C., Chou, Y., Chang, C., Lin, C., Chu, H., Chen, H.-D., Liu, T., Juan, Y., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.5034 · Cited by 6
Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations
Toratani, K., Watanabe, M., Kanda, J., Oka, T., Hyuga, M., Arai, Y., Iwasaki, M., Sakurada, M., Nannya, Y., Ogawa, S., et al. (2023) · International Journal of Hematology · doi:10.1007/s12185-023-03575-1 · Cited by 6
Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes
Hebert, R., Cullinan, N. M., Armstrong, L., Blood, K. A., Brossard, J., Brunga, L., Cacciotti, C., Caswell, K., Cellot, S., Coltin, H., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109376 · Cited by 6
Sarcoma Predisposition in Dogs with a Comparative View to Human Orthologous Disease
Arendt, M. L., & Dobson, J. M. (2023) · Veterinary Sciences · doi:10.3390/vetsci10070476 · Cited by 6
Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors
Groves, A. P., Ward, A., Li, Y. Y., de la Vega, L. L., Nag, A., Forrest, S. J., Gupta, H. V., Thorner, A. R., Meyerson, M. M., Kamihara, J., et al. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30643 · Cited by 6
Simultaneous Occurrence of Multiple Neoplasms in Children with Cancer Predisposition Syndromes: Collaborating with Abnormal Genes
Telman-Kołodziejczyk, G., Strauss, E., Sosnowska‐Sienkiewicz, P., Hałasz, M., & Januszkiewicz‐Lewandowska, D. (2023) · Genes · doi:10.3390/genes14091670 · Cited by 6
Germline mutations in cancer predisposition genes among pediatric patients with cancer and congenital anomalies
Dangoni, G. D., Teixeira, A. C. B., da Costa, S. S., Scliar, M. O., Carvalho, L. M. L., Silva, L. N., Novak, E. M., Vince, C. S. C., Maschietto, M. C., Sugayama, S. M. M., et al. (2024) · Pediatric Research · doi:10.1038/s41390-023-03000-7 · Cited by 6
Cross‐individual cancer transmission to children during the gestational and perinatal periods
Arakawa, A., Tao, K., Kohno, T., & Ogawa, C. (2024) · Cancer Science · doi:10.1111/cas.16102 · Cited by 5
Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene
Glushkova, M., Dimova, P., Yordanova, I., Todorov, T., Tourtourikov, I., Mitev, V., & Тодорова, А. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1372436 · Cited by 6
The Evidence for Expanded Genetic Testing for Pediatric Patients with Cancer
Maese, L. D., & Schiffman, J. D. (2018) · Future Oncology · doi:10.2217/fon-2017-0467 · Cited by 6
Germ line predisposition to myeloid malignancies appearing in adulthood
Crysandt, M. M., Brings, K., Beier, F., Thiede, C., Brümmendorf, T. H., & Jost, E. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1494566 · Cited by 7
A Pediatric Case of Transformed Mycosis Fungoides in a BRCA2 Positive Patient
Gross, A. M., Turner, J. T., Kirkorian, A. Y., Okoye, G. A., Luca, D. C., Bornhorst, M., Jacobs, S. S., Williams, K. M., & Schore, R. J. (2019) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001481 · Cited by 7
Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience
Chiang, J., Yuen, J., Shaw, T., Goh, H. X., Li, S.-T., Courtney, E., & Ngeow, J. Y. Y. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.568528 · Cited by 6
Cancer Predisposition in Neonates and Infants
Mitchell, S. G., Pencheva, B., Westfall, E., & Porter, C. C. (2021) · Clinics in Perinatology · doi:10.1016/j.clp.2020.11.001 · Cited by 6
Cancer predisposition genes in Japanese children with rhabdomyosarcoma
Fukushima, H., Suzuki, R., Yamaki, Y., Hosaka, S., Inaba, M., Morii, W., Noguchi, E., & Takada, H. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00961-7 · Cited by 6
Using Family History Forms in Pediatric Oncology to Identify Patients for Genetic Assessment
Hamilton, A., Smith, E., Hamon, J., Tomiak, E. M., Bassal, M., & Sawyer, S. L. (2017) · Current Oncology · doi:10.3747/co.24.3710 · Cited by 6
Pediatric genomics and precision medicine in childhood
Palau, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00014-9 · Cited by 6
The Potential and Challenges of Expanded Germline Testing in Clinical Oncology
Allen, E. M. V. (2017) · JAMA · doi:10.1001/jama.2017.11022 · Cited by 6
Germline pathogenic variants in 786 neuroblastoma patientsPreprint
Kim, J., Vaksman, Z., Egolf, L. E., Kaufman, R., Evans, P., Conkrite, K. L., Danesh, A., López, G., Randall, M. P., Dent, M. H., et al. (2023) · medRxiv · doi:10.1101/2023.01.23.23284864 · Cited by 6
Prevalence and characteristics of genetic disease in adult kidney stone formersPreprint
Anderegg, M. A., Olinger, E. G., Bargagli, M., Geraghty, R. M., Pohlmeier, L. M., Nater, A., Bruggmann, R., Sayer, J. A., Vogt, B., Schaller, A., et al. (2023) · medRxiv · doi:10.1101/2023.07.23.23292924 · Cited by 6
Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing
Wu, B., Shen, L., Peng, G., Li, Y., Zhou, Z., Li, J., Huang, X., Zhou, Q. C., Jiang, H., Huang, J., et al. (2022) · Oral Oncology · doi:10.1016/j.oraloncology.2022.106218 · Cited by 5
Self-citation
DNA repair and replicative stress addiction in neuroblastoma
Durinck, K., & Irwin, M. S. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100177 · Cited by 5
Fifth edition WHO classification: myeloid neoplasms
Chen, X., Patkar, N. V., Tembhare, P. R., Subramanian, P. G., Yeung, C., Kanagal‐Shamanna, R., Gujral, S., Wood, B. L., & Naresh, K. N. (2025) · Journal of Clinical Pathology · doi:10.1136/jcp-2024-210022 · Cited by 7
Self-citation
Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men
Gong, T., Jiang, J., Uthayopas, K., Bornman, R. M. S., Gheybi, K., Stricker, P. D., Weischenfeldt, J., Mutambirwa, S. B. A., Jaratlerdsiri, W., & Hayes, V. M. (2025) · Nature Communications · doi:10.1038/s41467-025-57312-9 · Cited by 7
The moderating role of parental cognitive perceptions in the link between children’s cancer predisposition genetic testing results and parent psychological adjustment
Sachner, L., Flynn, J. S., Hsu, C., Pan, H., Jurbergs, N., Blake, A., McGee, R. B., Harrison, L. W., Robinson, M., Adanri, T., et al. (2025) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsaf026 · Cited by 5
Self-citation
Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis
Sun, X., Wang, C., Metcalfe, D. D., Carter, M. C., & Marić, I. (2025) · British Journal of Haematology · doi:10.1111/bjh.20214 · Cited by 5
Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults
Daugs, K., Brandes, D., Yasin, L., Anwar, A., Alam, J., Prasad, Y., y Manns, J. B., Mescher, M., Fischer, U., Borkhardt, A., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70097 · Cited by 5
Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma
van Opijnen, M. P., van Valkengoed, D. R., de Ligt, J., Vos, F. D., Broekman, M. L. D., Cuppen, E. P. J. G., & Koster, R. (2025) · npj Genomic Medicine · doi:10.1038/s41525-025-00526-z · Cited by 6
The landscape of structural variation in pediatric cancer
Greenhalgh, R., Brady, S. W., Yang, W., Flasch, D. A., Edmonson, M. N., Terekhanova, N. V., Liu, Y., Wang, J., Szlachta, K. A., Tian, L., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.02.012 · Cited by 7
Self-citation
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with Osteosarcoma and Ependymoma
Kuhlen, M., Golas, M. M., Schaller, T., Stadler, N., Maier, F., Witt, O., & Frühwald, M. C. (2023) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-023-00254-4 · Cited by 5
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants
Ahmed, S., Wedekind, M. F., Rivero, J. D., Raygada, M. J., Lockridge, R., Glod, J. W., Flowers, C., Thomas, B., Bernstein, D. B., Kapustina, O. B., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0247 · Cited by 5
Cancer predisposing syndromes in childhood and adolescence pose several challenges necessitating interdisciplinary care in dedicated programs
Kaffai, S., Angelova-Toshkina, D., Weins, A. B., Ickinger, S., Steinke‐Lange, V., Vollert, K., Frühwald, M. C., & Kuhlen, M. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2024.1410061 · Cited by 5
Opportunities for Improving Detection of Cancer Predisposition Syndromes in Pediatric Solid Tumor Patients
Hu, B. Y., Kirkey, D. C., Wakeling, A., McGuinness, M., Kreimer, S., Crane, J. N., & Spunt, S. L. (2024) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002897 · Cited by 5
Characteristics and outcomes of secondary acute lymphoblastic leukemia (sALL) after multiple myeloma (MM): SEER data analysis in a single-center institution
Jia, J., Yin, J., Geng, C., & Liu, A. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.06.007 · Cited by 5
Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree
Gao, J., Wu, Y., Yu, J., Qiu, Y., Yi, T., Luo, C., Zhang, J., Lu, G. G., Li, X., Xiong, F., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.7394 · Cited by 5
Self-citation
Prevalence of the cancer-associated germline variants in Russian adults and long-living individuals: using the ACMG recommendations and computational interpreters for pathogenicity assessment
Gusakova, M., Dzhumaniiazova, I., Андреевна, З. Е., Kashtanova, D. A., Ivanov, M. V., Мамчур, А. А., Rumyantseva, A. M., Terekhov, M. V., Игоревич, М. С., Golubnikova, L. A., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1420176 · Cited by 5
Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer
Stricker, E., Peckham‐Gregory, E. C., Lai, S. Y., Sandulache, V. C., & Scheurer, M. E. (2024) · Microorganisms · doi:10.3390/microorganisms12122435 · Cited by 5
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium
Corbett, R. J., Gullickson, C., Geng, Z., Brown, M., Zhang, B., Zhong, C., Kuren, N. V., Chroni, A., Blackden, C., Naqvi, A. S., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf017 · Cited by 5
Germline Mutations Associated with Leukemia in Childhood: New Discoveries and Emerging Phenotypes
Bannon, S. A., Foglesong, J., & Dinardo, C. D. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0118-5 · Cited by 5
Psychosocial Aspects of Childhood Cancer Genetics
Patenaude, A. F., & Wakefield, C. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-74448-9_15 · Cited by 5
BRCA1/BRCA2 variants of uncertain significance in clinical practice: A case report
Huszno, J., Pigłowski, W., Mazur, M., Pamuła‐Piłat, J., Zajkowicz, A., Fiszer-Kierzkowska, A., & Wojciechowska, M. (2021) · Molecular and Clinical Oncology · doi:10.3892/mco.2021.2385 · Cited by 5
Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
Gao, J., Chen, Y., & SUKHANOVA, M. J. (2021) · Life · doi:10.3390/life12010046 · Cited by 5
From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research
Muñoz‐Barrera, A., Rubio‐Rodríguez, L. A., Usera, A. D.-D., Jáspez, D., Lorenzo-Salazar, J. M., González‐Montelongo, R., García‐Olivares, V., & Flores, C. (2022) · Life · doi:10.3390/life12111939 · Cited by 7
Recent progress in pediatric lymphoblastic leukemia
Kato, M. (2022) · International Journal of Hematology · doi:10.1007/s12185-022-03501-x · Cited by 5
SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome
Fiorentini, E., Giunti, L., Rita, A. D., Peraio, S., Fonte, C., Caporalini, C., Buccoliero, A. M., Censullo, M. L., Gori, G., Noris, A., et al. (2023) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2023.104784 · Cited by 5
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study
Fuentes-Bolanos, N., Padhye, B. D., Daley, M., Hunter, J. D., Hetherington, K., Warby, M., Courtney, E., Kirk, J., Josephi‐Taylor, S., Chen, Y., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070082 · Cited by 5
Hereditary Conditions Associated with Elevated Cancer Risk in Childhood
Suspitsin, E. N., & Имянитов, Е. Н. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070039 · Cited by 5
Gene–Environment Analyses Reveal Novel Genetic Candidates with Prenatal Tobacco Exposure in Relation to Risk for Childhood Acute Lymphoblastic Leukemia
Zhong, C., Li, S., Arroyo, K., Morimoto, L. M., de Smith, A. J., Metayer, C., Ma, X., Kogan, S. C., Gauderman, W. J., & Wiemels, J. L. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0258 · Cited by 5
Self-citation
Laser interstitial thermal therapy as a radiation-sparing approach for central nervous system tumors in children with cancer predisposition syndromes: report of a child with Li-Fraumeni syndrome. Illustrative case
Guadix, S. W., Pandey, A., Gundlach, C., Walsh, M. F., Moss, N. S., & Souweidane, M. M. (2024) · Journal of Neurosurgery Case Lessons · doi:10.3171/case23595 · Cited by 5
Self-citation
Germline susceptibility from broad genomic profiling of pediatric brain cancers
Mardis, E. R., Potter, S. L. P., Schieffer, K. M., Varga, E. A., Mathew, M. T., Costello, H. M., Wheeler, G., Kelly, B., Miller, K. E., Garfinkle, E. A. R., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae099 · Cited by 5
Self-citation
TRMT10C gene polymorphisms confer hepatoblastoma susceptibility: evidence from a seven-center case-control study
Liu, Y., Zhu, J., Wang, X.-Q., Zhang, W., Li, Y., Yang, Z., Zhang, J., Cheng, J., Li, L., Li, S., et al. (2024) · Journal of Cancer · doi:10.7150/jca.98555 · Cited by 5
Self-citation
Molecular characterization of gliomas and glioneuronal tumors amid Noonan syndrome: cancer predisposition examined
Shatara, M., Schieffer, K. M., Melas, M., Varga, E. A., Thomas, D., Bucknor, B. A., Costello, H. M., Wheeler, G., Kelly, B., Miller, K. E., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453309 · Cited by 5
Self-citation
Clinical Practice Recommendations Based on an Updated Review of Breast Cancer Risk Among Women Treated for Childhood Cancer
Derman, Y. E. (2017) · Journal of Pediatric Oncology Nursing · doi:10.1177/1043454217727515 · Cited by 5
Predominance of girls with cancer in families with multiple childhood cancer cases
Stjernfelt, K.-J., von Stedingk, K., Wiebe, T., Hjorth, L., Olsson, H. L., & Øra, I. (2017) · BMC Cancer · doi:10.1186/s12885-017-3899-8 · Cited by 5
Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience
Murray, K. S., Spaliviero, M., Tonorezos, E. S., Lacouture, M. E., Tap, W. D., Oeffinger, K. C., Vargas, H. A., & Eastham, J. A. (2018) · Urology · doi:10.1016/j.urology.2018.06.008 · Cited by 5
Genetic Mutations in B-Acute Lymphoblastic Leukemia Among African American and European American Children
Reddy, A., Espinoza, I. C., Cole, D., Schallheim, J., Poosarla, T., Bhanat, E. L., Zhou, Y., Zabaleta, J., MEGASON, G. C., & Gómez, C. R. (2018) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2018.08.003 · Cited by 5
Genetic Testing for Cancer Predisposition Syndromes in Adolescents and Young Adults (AYAs)
Cullinan, N. M., Capra, M. L., & McVeigh, T. P. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00187-7 · Cited by 6
Developing Novel Anticancer Drugs for Targeted Populations: An Update
Tafesse, T. B., Bule, M. H., Khan, F., Abdollahi, M. R., & Amini, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201124111748 · Cited by 5
Value of whole‐genome sequencing to Australian cancer patients and their first‐degree relatives participating in a genomic sequencing study
Butow, P. N., Davies, G., Napier, C. E., Bartley, N., Ballinger, M. L., Biesecker, B. B., Juraskova, I., Meiser, B., Schlub, T. E., Thomas, D. M., et al. (2021) · Journal of Genetic Counseling · doi:10.1002/jgc4.1455 · Cited by 5
A Case of Gorlin-Goltz Syndrome Without the Characteristic Physical Features That Was Diagnosed After the Development of a Fifth Cancer
Katayama, D., Inoue, A., Kayatani, R., Urabe, K., Suzuki, R., Takitani, K., Yoshida, M., Kato, M., & Ashida, A. (2022) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002436 · Cited by 5
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma
Doğan, İ., İribaş, A., Ahmed, M. A., & Başaran, M. (2022) · Journal of Chemotherapy · doi:10.1080/1120009x.2022.2104295 · Cited by 5
Secondary osteosarcoma: a challenge indeed
Meazza, C., Sironi, G., Nigro, O., Gattuso, G., Barretta, F., Podda, M. G., Luksch, R., Biassoni, V., Schiavello, E., Ferrari, A., et al. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02267-w · Cited by 5
Precision oncology for children: A primer for paediatricians
Cohen‐Gogo, S., Denburg, A., Villani, A., Thacker, N. H., Egan, G., Rafael, M., Malkin, D. M., & Morgenstern, D. A. (2023) · Paediatrics & Child Health · doi:10.1093/pch/pxac123 · Cited by 5
Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers
Yoshida, M., Nakabayashi, K., Yang, W., Sato‐Otsubo, A., Tsujimoto, S., Ogata‐Kawata, H., Kawai, T., Ishiwata, K., Sakamoto, M., Okamura, K., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.5835 · Cited by 5
Systematic analysis of Mendelian disease-associated gene variants reveals new classes of cancer-predisposing genes
Song, S., Koh, Y., Kim, S., Lee, S. M., Kim, H. U., Ko, J. M., Lee, S., Yoon, S., & Park, S. (2023) · Genome Medicine · doi:10.1186/s13073-023-01252-w · Cited by 5
Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma
Seo, E. S., Lee, J. W., Lim, J., Shin, S., Cho, H. W., Ju, H. Y., Yoo, K. H., Sung, K. W., & Park, W. (2024) · Nature Communications · doi:10.1038/s41467-024-52128-5 · Cited by 5
Epidemiology of Childhood Cancer
Whelan, K. F., & Alva, E. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48555-5.00001-6 · Cited by 5
When should transplant physicians think about familial blood cancers?
Trottier, A. M., Bannon, S. A., Bashir, Q., Carraway, H. E., Hofmann, I., & Godley, L. A. (2019) · Advances in Cell and Gene Therapy · doi:10.1002/acg2.68 · Cited by 5
Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer
Bobyn, A., Zarrei, M., Zhu, Y., Hoffman, M., Brenner, D. R., Resnick, A. C., Scherer, S. W., & Gallo, M. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01033-x · Cited by 5
Redefining “rare” in paediatric cancers
Pui, C., Pappo, A. S., Gajjar, A. J., & Downing, J. R. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00538-0 · Cited by 5
Self-citation
Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE)
Bagazgoïtia, N. V. D., Bailey, H. D., Orsi, L., Guerrini‐Rousseau, L., Bertozzi, A., Faure‐Conter, C., Leblond, P., Pellier, I., Freyçon, C., Doz, F., et al. (2019) · Cancer Causes & Control · doi:10.1007/s10552-019-01214-x · Cited by 5
Right to know and right to ignore in paediatric oncogenetics: Identifying biological causes, or seeking for meaning?
Bourdeaut, F. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.04.021 · Cited by 5
Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemiaPreprint
Schwartz, J. R., Walsh, M. P., Ma, J., Westover, T., Wang, S., Wu, G., Raimondi, S. C., Triplett, B. M., & Klco, J. M. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002980 · Cited by 6
Self-citation
Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germlinePreprint
Pendrick, D., Oberg, J. A., Hsiao, S. J., Chung, W. K., Koval, C., Sireci, A. N., Kuo, J. H., Satwani, P., Glasser, C. L., Sulis, M. L., et al. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003889 · Cited by 5
Developmental Dysregulation of Childhood CancerPreprint
Oliver, T. R. W., & Behjati, S. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041580 · Cited by 4
Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention
Kassem, N., Stout, L. A., Hunter, C., Schneider, B., & Radovich, M. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00278 · Cited by 5
FOXR2 activation is not exclusive of CNS neuroblastoma
Siskar, A. N., Hanzlik, E., Cardenas, M. F., Eldomery, M. K., Pinto, S. N., Tinkle, C. L., Zhang, Q.-Y., Li, X.-Y., Lin, T., Dhanda, S., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf076 · Cited by 4
Integration of ALK gene mutations and targeted therapies in pediatric high-risk neuroblastoma: advancements in precision oncology
Bheemavarapu, B., Khalil, M., Rehman, A., Javid, S., Cyrus, F., Qayyum, S. N., Gohil, A. V., Muneer, S. U., & Noori, S. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003697 · Cited by 5
Childhood Cancer Predisposition and Evolutionary Constraints: Novel Lessons from Germline Genomes from 1,127 Children with Cancer
Stoltze, U. K., Hansen, T. V. O., Foss-Skiftesvik, J., Byrjalsen, A., Henriksen, K. A., Laspiur, A. O., Gerdes, A., Ostrowski, S. R., Sørensen, E., Bak, M., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0153 · Cited by 4
Germline Cancer Predisposition Results From the National Cancer Institute—Children's Oncology Group Pediatric MATCH Trial
Scollon, S., Plon, S. E., Joffe, S., Biegel, J. A., Kulkarni, S., Miles, G., Patton, D. R., Coffey, B. D., Winter, C. L., Tsongalis, G. J., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00742 · Cited by 6
Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response
Tlais, D., Zhang, Q.-Y., Roach, J. T., Tinkle, C. L., Lin, T., Li, X.-Y., Mostafa, A. G., Moreira, D. C., McNall-Knapp, R., Rush, S. Z., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02992-w · Cited by 4
Simultaneous Detection of 2 Types of Malignancies in a Pediatric Patient on FDG PET/CT Led to Diagnosis of Li-Fraumeni Syndrome
Kan, Y., Si, Y., Wang, W., & Yang, J. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004266 · Cited by 4
Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers
Hayashi, N., Ono, M., Fukada, I., Yamazaki, M., Sato, N., Hosonaga, M., Wang, X., Kaneko, K., Arakawa, H., Habano, E., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103659 · Cited by 4
Overview of the etiology of childhood cancer and future directions
Hoang, T. T., Scheurer, M. E., & Lupo, P. J. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001419 · Cited by 6
Bone sarcomas and cancer predisposition syndromes
Tlemsani, C., Bougeard, G., Gauthier‐Villars, M., Denizeau, P., Winter, S., Michot, C., Baujat, G., Paillerets, B. B., de Beaumais, T. A., Rouchaud, A., et al. (2025) · Bulletin du Cancer · doi:10.1016/j.bulcan.2024.10.014 · Cited by 4
Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?
Lønning, P. E., Nikolaienko, O., & Knappskog, S. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00746 · Cited by 8
Pediatric Lymphoma and Solid Tumors Associated With Cancer Susceptibility Syndromes
Kara, B., & Köksal, Y. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001798 · Cited by 4
Childhood Cancer Predisposition: An Overview for the General Pediatrician
Kagami, L. A. T., Baldino, S. E., & MacFarland, S. P. (2022) · Pediatric Annals · doi:10.3928/19382359-20211207-01 · Cited by 4
Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer
De, B. S., Florez, M. A., Ludmir, E. B., Maor, M. H., McGovern, S. L., McAleer, M. F., Grosshans, D. R., Chang, E. L., Mahajan, A., & Paulino, A. C. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.06.055 · Cited by 4
Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, J., Song, H., Kim, S., Kim, S., Kwon, S. R., Lee, Y. E., Jeong, D., Park, J. H., Kwon, S., Yun, H., et al. (2023) · Human Genomics · doi:10.1186/s40246-023-00458-8 · Cited by 4
Molecular genomic landscape of pediatric solid tumors in Chinese patients: implications for clinical significance
Gong, J., Dong, L., Dong, L., 王传伟, Luo, N., Han, T., Zhu, X., Li, M., Sun, T., Ding, R., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04756-5 · Cited by 5
Optical genome mapping identifies structural variants in potentially new cancer predisposition candidate genes in pediatric cancer patients
Wagener, R., Brandes, D., Jung, M., Huetzen, M. A., Bergmann, A. K., Panier, S., Picard, D. J., Fischer, U., Jachimowicz, R. D., Borkhardt, A., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34721 · Cited by 4
Advancing Precision Medicine
Zalli, D., Mai, Z., Ferati, E., Ramaj, A., Bregu, R., & Pranjol, M. Z. I. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_413-1 · Cited by 4
SDHA secondary findings in germline testing: counseling and surveillance considerations
Skefos, C. M., Brock, P. L., Blouch, E. L., & Greenberg, S. E. (2024) · Endocrine Oncology · doi:10.1530/eo-23-0043 · Cited by 4
Genetic Predisposition to Sarcoma: What Should Clinicians Know?
Vagher, J., Mehrhoff, C. J., Florou, V., & Maese, L. D. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01192-6 · Cited by 4

Authors: Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
Affiliations: St. Jude Children's Research Hospital (US)
Washington University in St. Louis (US)
ORCID: Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Chen, Xiang
McGee, Rose B.
Nuccio, Regina
Quinn, Emily
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
Downing, James R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-12-10
Volume: 373
Issue: 24
Pages: 2336-2346
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508054
PMC: PMC4734119
OpenAlex: W2303408208
Cited by: 1,345
References: 56
Citations by year: 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
FWCI: 67.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Cancer Institute (R01CA180006, CA21765, P30CA021765)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
MeSH terms: Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Germline Mutations in Predisposition Genes in Pediatric Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks